Prostate cancer
Results
Phase 3
This trial looked at a drug called custirsen with chemotherapy for prostate cancer.It was for men whose:
cancer had spread to other parts of the body (advanced cancer)
hormone therapy had stopped working
This trial was open for men to join between 2010 and 2012. The researchers published results in 2017.
Recruitment start: 10 December 2010
Recruitment end: 7 November 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Johann De Bono
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Oncogenex
Teva Pharmaceutical Industries Ltd
Last reviewed: 3 July 2019
CRUK internal database number: 7860